Clinical Trial Update: Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Chronic, Moderate to Severe Osteoarthritis (OA) Pain [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the fentanyl transdermal matrix patch ZR-02-01 for chronic moderate-to-severe osteoarthritis pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• Fentanyl Transdermal Matrix Patch ZR-02-01 (fentanyl)

Snippet

Sponsor: ZARS Pharma Inc. | Conditions: Pain | Phase 2 | Status: COMPLETED